Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
Johnson, Julie A
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. [electronic resource] - American heart journal Mar 2009 - 442-9 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1097-6744
10.1016/j.ahj.2008.11.018 doi
Adolescent
Adrenergic beta-Antagonists--metabolism
Adult
Antihypertensive Agents--metabolism
Atenolol--metabolism
Blood Pressure Monitoring, Ambulatory
Diuretics--metabolism
Drug Therapy, Combination
Humans
Hydrochlorothiazide
Middle Aged
Pharmacogenetics
Research Design
Young Adult
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. [electronic resource] - American heart journal Mar 2009 - 442-9 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1097-6744
10.1016/j.ahj.2008.11.018 doi
Adolescent
Adrenergic beta-Antagonists--metabolism
Adult
Antihypertensive Agents--metabolism
Atenolol--metabolism
Blood Pressure Monitoring, Ambulatory
Diuretics--metabolism
Drug Therapy, Combination
Humans
Hydrochlorothiazide
Middle Aged
Pharmacogenetics
Research Design
Young Adult